Q32 Bio Inc.

Biotechnology • Healthcare • Waltham, MA, United States • QTTB (NCM)

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

PR Newswire • Aug 6

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - Stocktwits

Stocktwits • Dec 1

Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com

Investing.com • Dec 18

Q32 Bio Stock (QTTB) Opinions on ADX-097 Asset Sale - Quiver Quantitative

Quiver Quantitative • Dec 1

QTTB Stock Surges: Market Insight - StocksToTrade

StocksToTrade • Dec 1

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Q32 Bio Inc. had layoffs?

No layoff events have been recorded for Q32 Bio Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Q32 Bio Inc. have?

Q32 Bio Inc. has approximately 26 employees.

What industry is Q32 Bio Inc. in?

Q32 Bio Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Q32 Bio Inc. a publicly traded company?

Yes, Q32 Bio Inc. is publicly traded under the ticker symbol QTTB on the NCM. The company has a market capitalization of approximately $0.04 billion.

Where is Q32 Bio Inc. headquartered?

Q32 Bio Inc. is headquartered in Waltham, MA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.